Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Publications

Single-cell analyses reveal aberrant pathways for megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets

Psaila B. et al, (2019)

Single-cell profiling reveals key differences in the cellular architecture of human haematopoietic stem and progenitor cells throughout fetal and adult life

ROY A. et al, (2018)

A Single-Cell Approach to Unraveling Abnormal Megakaryocyte Differentiation and Function in Myelofibrosis

Psaila B. et al, (2017), BLOOD, 130

Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.

Vlachodimitropoulou E. et al, (2017), Blood, 130, 1923 - 1933

Pre-metastatic niches: organ-specific homes for metastases.

Peinado H. et al, (2017), Nature reviews. Cancer, 17, 302 - 317

Tense your megas! Structural rigidity is key.

Psaila B., (2016), Blood, 128, 1997 - 1999

SINGLE-CELL PROFILING OF HUMAN MEGAKARYOCYTE-ERYTHROID PROGENITORS IDENTIFIES DISTINCT MEGAKARYOCYTE AND ERYTHROID DIFFERENTIATION PATHWAYS

Psaila B. et al, (2016), HAEMATOLOGICA, 101, 21 - 21

Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways

Psaila B. et al, (2016), Genome Biology

A Potential Novel Application of Eltrombopag: A Combination Agent to Enhance Iron Chelation Therapy

Koumoutsea EV. et al, (2015), BLOOD, 126

PROSPECTIVE ISOLATION OF NOVEL POPULATIONS OF MEGAKARYOCYTE-AND ERYTHROID-PRIMED MEGAKARYOCYTE-ERYTHROID PROGENITORS DEMONSTRATES MEGAKARYOCYTE-BIASED LINEAGE COMMITMENT IN PRIMARY MYELOFIBROSIS

Psaila B. et al, (2015), HAEMATOLOGICA, 100, 97 - 97

B-cell depletion in immune thrombocytopenia.

Psaila B. and Cooper N., (2015), Lancet, 385, 1599 - 1601

Elucidation of the EP defect in Diamond-Blackfan anemia by characterization and prospective isolation of human EPs.

Iskander D. et al, (2015), Blood, 125, 2553 - 2557

Eltrombopag Mobilizes Intracellular Iron Stores at Concentrations Lower Than Those Required with Other Clinically Available Iron Chelators

Koumoutsea EV. et al, (2014), BLOOD, 124

Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.

Mitchell WB. et al, (2014), Am J Hematol, 89, E228 - E234

The Influence Of KIR Haplotype In ITP Incidence, Treatment Response and Bleeding Symptoms

Psaila B. et al, (2013), BLOOD, 122

Immune Thrombocytopenia (ITP)

Psaila B. and Bussel JB., (2013), Platelets, 819 - 833

Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia: a reply to a rebuttal.

Psaila B. et al, (2013), J Thromb Haemost, 11, 1002 - 1003

In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation.

Psaila B. et al, (2012), Blood, 119, 4066 - 4072

Megakaryocytes, malignancy and bone marrow vascular niches.

Psaila B. et al, (2012), J Thromb Haemost, 10, 177 - 188

Immune Thrombocytopenia (ITP)

Psaila B. and Bussel JB., (2012), Platelets, Third Edition, 819 - 833